Validation and Optimization of an Ex Vivo Assay of Intestinal Mucosal Biopsies in Crohn's Disease: Reflects Inflammation and Drug Effects.
Crohn's disease (CD) is a chronic illness demanding better therapeutics. The marketed biologics only benefit some patients or elicit diminishing effect over time. To complement the known methods in drug development and to obtain patient specific drug responses, we optimized and validated a know...
Main Authors: | Kasper Vadstrup, Elisabeth Douglas Galsgaard, Jens Gerwien, Marianne Kajbæk Vester-Andersen, Julie Steen Pedersen, Julie Rasmussen, Søren Neermark, Marianne Kiszka-Kanowitz, Teis Jensen, Flemming Bendtsen |
---|---|
Format: | Article |
Language: | English |
Published: |
Public Library of Science (PLoS)
2016-01-01
|
Series: | PLoS ONE |
Online Access: | http://europepmc.org/articles/PMC4865152?pdf=render |
Similar Items
-
High Abundance of Proteobacteria in Ileo-Anal Pouch Anastomosis and Increased Abundance of Fusobacteria Associated with Increased Pouch Inflammation
by: Andreas Munk Petersen, et al.
Published: (2020-05-01) -
Effects of Roux-en-Y Gastric Bypass and Sleeve Gastrectomy on Non-Alcoholic Fatty Liver Disease: A 12-Month Follow-Up Study with Paired Liver Biopsies
by: Julie Steen Pedersen, et al.
Published: (2021-08-01) -
The cost burden of Crohn’s disease and ulcerative colitis depending on biologic treatment status – a Danish register-based study
by: Sarah Alulis, et al.
Published: (2021-08-01) -
Systematic review and meta-analysis: the impact of co-occurring immune-mediated inflammatory diseases on the disease localization and behavior of Crohn’s disease
by: Mohamed Attauabi, et al.
Published: (2021-06-01) -
Additional information obtained from mucosal biopsies is limited after pan-enteric capsule endoscopy in patients with suspected Crohn’s disease
by: Sofia Hjerrild Thomsen, et al.
Published: (2023-10-01)